Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rVIIa for salvage haemostasis in complex cardiac surgery
NCT00214656Phase 3Unknown
- Sponsor
- Austin Health
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of coagulation factor VIIa in coagulopathy (2 arms), sponsored by Austin Health. Primary endpoint: Adequate haemostasis to enable chest closure after administration of trial medication without the need for further intervention. Status: unknown.
02
Drugs
coagulation factor VIIa
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT00214656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214656.